AAAAAA

   
Results: 1-10 |
Results: 10
SPLENIC PATHOLOGY IN MYELODYSPLASIA - A REPORT OF 13 CASES WITH CLINICAL CORRELATION
Authors: KRAUS MD BARTLETT NL FLEMING MD DORFMAN DM
Citation: Md. Kraus et al., SPLENIC PATHOLOGY IN MYELODYSPLASIA - A REPORT OF 13 CASES WITH CLINICAL CORRELATION, The American journal of surgical pathology, 22(10), 1998, pp. 1255-1266
BONE-MARROW STAGING IN PATIENTS WITH NON-HODGKINS-LYMPHOMA - IS FLOW-CYTOMETRY A USEFUL TEST
Authors: NAUGHTON MJ HESS JL ZUTTER MM BARTLETT NL
Citation: Mj. Naughton et al., BONE-MARROW STAGING IN PATIENTS WITH NON-HODGKINS-LYMPHOMA - IS FLOW-CYTOMETRY A USEFUL TEST, Cancer, 82(6), 1998, pp. 1154-1159
ASSESSMENT OF KNOWLEDGE ABOUT CANCER PAIN MANAGEMENT BY PHYSICIANS IN-TRAINING
Authors: MORTIMER JE BARTLETT NL
Citation: Je. Mortimer et Nl. Bartlett, ASSESSMENT OF KNOWLEDGE ABOUT CANCER PAIN MANAGEMENT BY PHYSICIANS IN-TRAINING, Journal of pain and symptom management, 14(1), 1997, pp. 21-28
IN-VIVO QUANTIFICATION OF THE EFFECT OF P-GLYCOPROTEIN INHIBITOR PSC833 ON THE BIOKINETICS OF TC-99M SESTAMIBI
Authors: PHUNG NX BARTLETT NL FRACASSO PM PIWNICAWORMS D ROYAL HD
Citation: Nx. Phung et al., IN-VIVO QUANTIFICATION OF THE EFFECT OF P-GLYCOPROTEIN INHIBITOR PSC833 ON THE BIOKINETICS OF TC-99M SESTAMIBI, The Journal of nuclear medicine, 38(5), 1997, pp. 1022-1022
12 WEEKS OF CHEMOTHERAPY (STANFORD V) AND INVOLVED FIELD RADIOTHERAPY(RT) ARE HIGHLY EFFECTIVE FOR BULKY AND ADVANCED-STAGE HODGKINS-DISEASE (HD) - A LIMITED INSTITUTION ECOG PILOT-STUDY
Authors: HORNING SJ BENNETT JM BARTLETT NL WILLIAMS J NEUBERG D CASSILETH PA
Citation: Sj. Horning et al., 12 WEEKS OF CHEMOTHERAPY (STANFORD V) AND INVOLVED FIELD RADIOTHERAPY(RT) ARE HIGHLY EFFECTIVE FOR BULKY AND ADVANCED-STAGE HODGKINS-DISEASE (HD) - A LIMITED INSTITUTION ECOG PILOT-STUDY, Blood, 88(10), 1996, pp. 2681-2681
BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT
Authors: BARTLETT NL ROSENBERG SA HOPPE RT HANCOCK SL HORNING SJ
Citation: Nl. Bartlett et al., BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT, Journal of clinical oncology, 13(5), 1995, pp. 1080-1088
FOLLICULAR LARGE-CELL LYMPHOMA - INTERMEDIATE OR LOW-GRADE
Authors: BARTLETT NL RIZEQ M DORFMAN RF HALPERN J HORNING SJ
Citation: Nl. Bartlett et al., FOLLICULAR LARGE-CELL LYMPHOMA - INTERMEDIATE OR LOW-GRADE, Journal of clinical oncology, 12(7), 1994, pp. 1349-1357
PHASE-I TRIAL OF DOXORUBICIN WITH CYCLOSPORINE AS A MODULATOR OF MULTIDRUG-RESISTANCE
Authors: BARTLETT NL LUM BL FISHER GA BROPHY NA EHSAN MN HALSEY J SIKIC BI
Citation: Nl. Bartlett et al., PHASE-I TRIAL OF DOXORUBICIN WITH CYCLOSPORINE AS A MODULATOR OF MULTIDRUG-RESISTANCE, Journal of clinical oncology, 12(4), 1994, pp. 835-842
PHARMACODYNAMICS (PD) OF DOXORUBICIN (DOX) WITH CYCLOSPORINE (CSA) ASA MODULATOR OF DRUG-RESISTANCE
Authors: LUM BL BARTLETT NL FISHER GA BROPHY NA EHSAN M HALSEY J SIKIC BI
Citation: Bl. Lum et al., PHARMACODYNAMICS (PD) OF DOXORUBICIN (DOX) WITH CYCLOSPORINE (CSA) ASA MODULATOR OF DRUG-RESISTANCE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 210-210
MACOP-B + - RADIATION-THERAPY FOR DIFFUSE LARGE-CELL LYMPHOMA - ANALYSIS OF THE STANFORD RESULTS ACCORDING TO PROGNOSTIC INDEXES/
Authors: BARTLETT NL KWAK LW HORNING SJ
Citation: Nl. Bartlett et al., MACOP-B + - RADIATION-THERAPY FOR DIFFUSE LARGE-CELL LYMPHOMA - ANALYSIS OF THE STANFORD RESULTS ACCORDING TO PROGNOSTIC INDEXES/, Cancer, 71(12), 1993, pp. 4034-4042
Risultati: 1-10 |